Aegon Ltd.

DB:J060 Stock Report

Market Cap: €9.2b

Aegon Valuation

Is J060 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of J060 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: J060 (€5.66) is trading below our estimate of fair value (€14.93)

Significantly Below Fair Value: J060 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for J060?

Key metric: As J060 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for J060. This is calculated by dividing J060's market cap by their current revenue.
What is J060's PS Ratio?
PS Ratio0.7x
Sales€12.73b
Market Cap€9.22b

Price to Sales Ratio vs Peers

How does J060's PS Ratio compare to its peers?

The above table shows the PS ratio for J060 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.8x
WUW Wüstenrot & Württembergische
0.2xn/a€1.1b
TLX Talanx
0.4x7.9%€21.1b
HNR1 Hannover Rück
1.1x2.5%€29.4b
G07 Great Eastern Holdings
1.7xn/aS$12.2b
J060 Aegon
0.7x-4.5%€9.2b

Price-To-Sales vs Peers: J060 is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (0.8x).

Price to Sales Ratio vs Industry

How does J060's PS Ratio compare vs other companies in the European Insurance Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
J060 0.7xIndustry Avg. 1.0xNo. of Companies13PS00.61.21.82.43+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: J060 is good value based on its Price-To-Sales Ratio (0.7x) compared to the European Insurance industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is J060's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

J060 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.7x
Fair PS Ratio0.8x

Price-To-Sales vs Fair Ratio: J060 is good value based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst J060 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€5.66
€6.64
+17.2%
11.3%€8.00€5.40n/a15
Dec ’25€6.07
€6.57
+8.3%
10.8%€8.00€5.40n/a15
Nov ’25€5.81
€6.27
+7.9%
11.5%€7.65€4.80n/a15
Oct ’25€5.59
€6.28
+12.3%
11.5%€7.65€4.80n/a15
Sep ’25€5.48
€6.26
+14.4%
11.7%€7.65€4.80n/a15
Aug ’25€5.74
€6.11
+6.6%
14.1%€7.50€4.30n/a15
Jul ’25€5.79
€6.10
+5.4%
14.4%€7.60€4.30n/a15
Jun ’25€5.91
€6.06
+2.5%
15.3%€8.00€4.30n/a14
May ’25€5.79
€5.90
+1.9%
12.0%€7.00€4.30n/a15
Apr ’25€5.62
€5.84
+3.9%
11.6%€7.00€4.30n/a15
Mar ’25€5.20
€5.88
+13.1%
11.3%€7.00€4.30n/a16
Feb ’25€5.42
€5.76
+6.3%
11.5%€7.00€4.30n/a16
Jan ’25€5.24
€5.49
+4.7%
12.0%€6.75€4.00n/a15
Dec ’24€5.05
€5.48
+8.5%
12.0%€6.75€4.00€6.0715
Nov ’24€4.59
€5.38
+17.1%
13.6%€6.75€3.60€5.8115
Oct ’24€4.51
€5.45
+20.8%
13.3%€6.75€3.60€5.5914
Sep ’24€4.74
€5.39
+13.6%
13.4%€6.75€3.60€5.4815
Aug ’24€4.94
€5.38
+8.8%
14.1%€6.75€3.60€5.7414
Jul ’24€4.64
€5.39
+16.0%
13.8%€6.75€3.60€5.7915
Jun ’24€4.17
€5.33
+28.0%
15.0%€6.75€3.60€5.9114
May ’24€4.12
€5.33
+29.6%
15.1%€6.75€3.60€5.7914
Apr ’24€3.97
€5.38
+35.6%
15.5%€6.75€3.60€5.6214
Mar ’24€4.91
€5.38
+9.5%
15.5%€6.75€3.60€5.2014
Feb ’24€5.02
€5.29
+5.4%
14.7%€6.75€3.60€5.4214
Jan ’24€4.75
€5.18
+9.1%
14.8%€6.75€3.50€5.2415
Dec ’23€4.70
€5.19
+10.5%
14.8%€6.75€3.50€5.0515

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 09:09
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aegon Ltd. is covered by 48 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Cor KluisABN AMRO Bank N.V.
Maria del Paz Ojeda FernandezAhorro Corporación
Andrew BroadfieldBarclays